TITLE

Epilepsy Update

PUB. DATE
March 2006
SOURCE
PharmaWatch: CNS;Mar2006, Vol. 5 Issue 3, p6
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
The article reports on developments about drugs for treating epilepsy. The U.S. Food and Drug Administration has requested more information before approving the intravenous version of UCB SA's Keppra drug. Keppra was also recommended for approval by an advisory committee to the European Medicines Agency. Teva Pharmaceutical Industries Ltd. has been given tentative approval to market Divalproex, a generic version of Abbott Laboratories' Depakote.
ACCESSION #
20232702

 

Related Articles

  • Chain PHARMACY: REPORTERS Notebook.  // Drug Store News;5/13/2013, Vol. 35 Issue 5, p53 

    The article offers news briefs related to the generic drug industry including the launch of oxymorphone hydrochloride tablets by Teva Pharmaceutical Industries, the approval of the Daysee contraceptives from Lupin Pharmaceuticals by the U.S. Food and Drug Administration and Sandoz's launch of...

  • Teva branches out from generics. Mirasol, Feliza // Chemical Market Reporter;6/5/2006, Vol. 269 Issue 22, p22 

    The article focuses on the broadening of Teva Pharmaceutical Industries Ltd. beyond the generic drug sector. With the approval of Azilect, a drug for Parkinson's disease, the company enhances its reputation as a global drug firm. The drug was developed by the company based on initial research...

  • Teva introduces Tromethamine as generics medication.  // Drug Store News;8/24/98, Vol. 20 Issue 13, pCP98 

    Reports on the launching of Teva Pharmaceuticals USA's generic Ketorolac Tromethamine Tablets USP 10 milligram. Cost-saving alternative; Contact information.

  • Teva: GSK's latest headache.  // PharmaWatch: Monthly Review;Jan2007, Vol. 6 Issue 1, p21 

    The article discusses the tentative approval received by Teva Pharmaceutical Industries Ltd. from the U.S. Food and Drug Administration for its sumatriptan succinate. Teva joins other companies who received tentative approval for the generic Imitrex or successfully settled patent litigation with...

  • GENERICS NEWSLINE.  // Monthly Prescribing Reference;Jan2016, Vol. 32 Issue 1, pA18 

    The article offers world news related to the generic drug industry as of January 1, 2016. Topics include the launch of the Clozapine Orally Disintegrating Tablets, the generic version of the FazaClo atypical antipsychotic drug, by Mylan NV, the approval of the Blisovi Fe 1/20 and Blisovi 1.5/30...

  • GENERICS NEWSLINE.  // Monthly Prescribing Reference;Jul2015, Vol. 31 Issue 7, pA11 

    The article offers news briefs related to generic drugs industry as of July 2015. Topics include the launch of the Risedronate Sodium Tablets from pharmaceutical company Teva, an approval received by pharmaceutical company Aurobindo Pharma from the U.S. Food and Drug Administration (FDA) for the...

  • Generic Pravastatin Approved.  // FDA Consumer;Jul/Aug2006, Vol. 40 Issue 4, p5 

    The article reports on the approval of the first generic version of Bristol-Myers Squibb's Pravachol (pravastatin sodium) Tablets by the U.S. Food and Drug Administration for the treatment of individuals who have high cholesterol levels (hyperlipidemia) or who are at increased risk for...

  • Food and Drug Administration Approves Generic Products From Teva, Mylan and Impax.  // Chemical Market Reporter;4/5/2004, Vol. 265 Issue 14, p13 

    Reports on the approval of generic formulations from several generic drug maker by the Food and Drug Administration (FDA) in the U.S. Receipt of approval for generic version of Purdue Frederick Company's brand name pain medication by Teva Pharmaceutical Industries Ltd.; Issuance of FDA of a...

  • How close is close enough. Challener, Cynthia // ICIS Chemical Business;3/10/2008, Vol. 273 Issue 10, p30 

    The article focuses on a controversy raised against the U.S. Food & Drug Administration (FDA) for granting approval of Budeprion XL 300, a Teva Pharmaceutical Industries Ltd.-manufactured generic form of the antidepressant Wellbutrin XL. The controversy follows complaints filed against...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics